Auburn, AL, April 28, 2021 – Aptar CSP Technologies, a leader in material science and active packaging solutions (part of AptarGroup, Inc.), announced its Activ-Film™ technology was selected to protect two new at-home COVID-19 tests that recently received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA).
The tests were developed by a leading manufacturer of diagnostic healthcare solutions and offer prescription and OTC (Over the Counter) COVID-19 at-home testing options without the need to visit a doctor’s office.
Aptar CSP’s Activ-Film™ technology is integrated into the dipstick of the diagnostic kits to protect against moisture and other environmental conditions that could otherwise impact test accuracy. Activ-Film™ leverages Aptar’s proprietary 3-Phase Activ-Polymer™ platform technology, which provides a broad spectrum of customized and highly-engineered solutions in a variety of configurations, such as Activ-Vial™ for housing diagnostics strips and dipsticks, and Activ-Tab™, which is integrated within diagnostic cassettes. This material science-based active packaging technology currently protects a range of lateral flow, molecular, and electrochemical diagnostic test kits on the market today, including Quidel® Corporation’s QuickVue® Influenza and COVID-19 tests.
“As we continue to navigate through the COVID-19 crisis, this game-changing solution will help meet the urgent demand for COVID-19 testing in communities around the world,” said Badre Hammond, Vice President Commercial Operations, Aptar CSP Technologies. “We are committed to leveraging our material science expertise to enable our partners to meet the ongoing need for innovative healthcare solutions that help improve and save lives. This is another example of the value we bring to the market when sensitive diagnostic elements need protection.”
More information about the new at-home COVID-19 tests is available on the FDA website.
###
About Aptar CSP Technologies
Aptar CSP Technologies is part of AptarGroup, Inc., a global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing and material science solutions. Aptar’s innovative solutions and services serve a variety of end markets including pharmaceutical, beauty, personal care, home, food and beverage. Using insights, proprietary design, engineering and science to create dispensing, dosing and protective packaging technologies for many of the world’s leading brands, Aptar in turn makes a meaningful difference in the lives, looks, health and homes of millions of patients and consumers around the world. Aptar is headquartered in Crystal Lake, Illinois and has 13,000 dedicated employees in 20 countries. For more information, visit www.aptar.com.
Aptar CSP Technologies is the premier active material science solutions expert that transforms ideas into market opportunities, accelerates and de-risks the product development process, and provides complete solutions that improve consumers’ and patients’ lives. A global material science company, CSP provides innovative, highly-engineered active packaging solutions to protect sensitive products. CSP is a responsive, flexible partner committed to offering customers a single, reliable source for custom product design, development, and manufacturing. CSP has a proven track record of pioneering technological solutions that ensure product protection and enhance its customers’ brand equity. For more information, visit www.csptechnologies.com.
